Jefferies Initiates La Jolla Pharma With Buy By: Benzinga via Benzinga August 04, 2014 at 08:39 AM EDT Analysts at Jefferies initiated coverage on La Jolla Pharma (NASDAQ: LJPC) with a Buy rating. The target price for La Jolla Pharma ... Read More >> Related Stocks: LA Jolla Pharma